Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 60.27M | 63.52M | 377.71M | 60.92M | 51.84M | 24.00K |
Gross Profit | 2.22M | 63.52M | -59.67M | 38.34M | 35.40M | -103.16M |
EBITDA | -396.47M | -383.98M | -156.47M | -324.33M | -392.46M | -128.03M |
Net Income | -398.58M | -376.74M | -132.53M | -263.59M | -341.36M | -256.42M |
Balance Sheet | ||||||
Total Assets | 1.39B | 1.10B | 1.46B | 1.34B | 1.47B | 451.68M |
Cash, Cash Equivalents and Short-Term Investments | 1.15B | 850.74M | 1.19B | 1.08B | 965.65M | 299.67M |
Total Debt | 154.80M | 161.43M | 172.69M | 179.00M | 142.35M | 100.23M |
Total Liabilities | 344.34M | 370.28M | 478.38M | 608.24M | 647.72M | 206.12M |
Stockholders Equity | 1.05B | 733.54M | 981.33M | 733.47M | 826.74M | 245.56M |
Cash Flow | ||||||
Free Cash Flow | -355.57M | -356.19M | -182.93M | -26.42M | -113.08M | -112.10M |
Operating Cash Flow | -344.82M | -347.25M | -149.19M | 22.53M | -66.27M | -95.74M |
Investing Cash Flow | -144.52M | 185.01M | 71.84M | -461.34M | -294.14M | -100.12M |
Financing Cash Flow | 479.19M | 7.74M | 276.45M | 111.59M | 756.14M | 322.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | 1.73B | -82.40 | -5.23% | ― | 26.90% | 62.72% | |
58 Neutral | 2.07B | -22.47 | -67.11% | ― | 99.50% | 65.91% | |
50 Neutral | $2.39B | ― | -41.94% | ― | -82.90% | -155.64% | |
45 Neutral | 1.97B | -4.78 | ― | ― | -100.00% | 1.62% | |
45 Neutral | 2.69B | -5.51 | ― | ― | ― | -48.38% | |
43 Neutral | 2.17B | -13.97 | ― | ― | ― | -22.19% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
On July 1, 2025, Beam Therapeutics Inc. acquired an early-stage life sciences company, agreeing to issue 403,128 shares of its common stock as an upfront payment and up to $89 million in additional milestone payments. This strategic acquisition is expected to enhance Beam’s capabilities and market position, potentially impacting its operations and stakeholders positively.